FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
| Olodanrigan, 1348410-84-3 ;1316755-16-4 (free), Olodanrigan Intermediate 1871-76-7, stock 945.5g, white powder, assay by HPLC 99.9%, HNMR, LCMS we supply. |
| Olodanrigan, 1348410-84-3 ;1316755-16-4 (free), Olodanrigan Intermediate 551909-81-0, stock 582.3g, white powder, assay by HPLC 99.7%, HNMR, LCMS we supply. |
| Olodanrigan, 1348410-84-3 ;1316755-16-4 (free), Olodanrigan Intermediate 1356460-51-9, stock 710.4g, white powder, assay by HPLC 98.8%, HNMR, LCMS we supply. |
| Olodanrigan, 1348410-84-3 ;1316755-16-4 (free), Olodanrigan Intermediate 1316755-16-4, stock 676.2g, white powder, assay by HPLC 99%, HNMR, LCMS we supply. |
| Olodanrigan, 1348410-84-3 ;1316755-16-4 (free), Olodanrigan Intermediate 1316755-16-4, stock 156.4g, white powder, assay by HPLC 99.7%, HNMR, LCMS we supply. |
